Rahul Baxi, a Mumbai-based diabetologist, is inundated with patients seeking the new weight-loss injection, Mounjaro, priced at ₹16,000 per month in India. Dr. Baxi emphasizes the importance of lifestyle changes alongside the injection, as it mimics hormones to aid in weight loss but comes with risks like gastrointestinal issues. Ideal candidates include those with Type 2 diabetes or significant weight issues, but pregnant women and individuals with certain health conditions should avoid it.
Full Article
Loading PerspectiveSplit analysis...
